Abstract
NOMI is a severe disease associated with a mortality rate of 70 %. In order to achieve the best result, a timely diagnosis is of the utmost importance. Besides general treatment of mesenteric ischemia, treatment should be focused on relieving the vasospasm to return adequate blood flow to the splanchnic circulation. Treatment with intra-arterial papaverine can successfully relieve mesenteric vasoconstriction, although mesenteric angiography may not be possible due to an unfavorable patient presentation. A good alternative is the application of a high dose of intravenous PGE1. Surgical intervention should be reserved for patients in whom initial treatment fails.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sise MJ. Mesenteric ischemia: the whole spectrum. Scand J Surg. 2010;99(2):106–10. PubMed PMID: 20679047.
Oldenburg WA, Lau LL, Rodenberg TJ, Edmonds HJ, Burger CD. Acute mesenteric ischemia: a clinical review. Arch Intern Med. 2004;164(10):1054–62. PubMed PMID: 15159262.
Schoots IG, Koffeman GI, Legemate DA, Levi M, van Gulik TM. Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br J Surg. 2004;91(1):17–27. PubMed PMID: 14716789.
Boley SJ, Sprayregan S, Siegelman SS, Veith FJ. Initial results from an aggressive roentgenological and surgical approach to acute mesenteric ischemia. Surgery. 1977;82(6):848–55. PubMed PMID: 929375.
Trompeter M, Brazda T, Remy CT, Vestring T, Reimer P. Non-occlusive mesenteric ischemia: etiology, diagnosis, and interventional therapy. Eur Radiol. 2002;12(5):1179–87. PubMed PMID: 11976865.
Gewertz BL, Zarins CK. Postoperative vasospasm after antegrade mesenteric revascularization: a report of three cases. J Vasc Surg. 1991;14(3):382–5. PubMed PMID: 1880846.
Mitsuyoshi A, Obama K, Shinkura N, Ito T, Zaima M. Survival in nonocclusive mesenteric ischemia: early diagnosis by multidetector row computed tomography and early treatment with continuous intravenous high-dose prostaglandin E(1). Ann Surg. 2007;246(2):229–35. PubMed PMID: 17667501. Pubmed Central PMCID: 1933563.
Tabriziani H, Frishman WH, Brandt LJ. Drug therapies for mesenteric vascular disease. Heart Dis. 2002;4(5):306–14. PubMed PMID: 12350243.
Bozlar U, Turba UC, Hagspiel KD. Nonocclusive mesenteric ischemia: findings at multidetector CT angiography. J Vasc Interv Radiol. 2007;18(10):1331–3. PubMed PMID: 17911529.
Wyers MC. Acute mesenteric ischemia: diagnostic approach and surgical treatment. Semin Vasc Surg. 2010;23(1):9–20. PubMed PMID: 20298945.
Cawello W, Schweer H, Muller R, Bonn R, Seyberth HW. Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects. Eur J Clin Pharmacol. 1994;46(3):275–7. PubMed PMID: 8070511.
Kamimura K, Oosaki A, Sugahara S, Mori S. Survival of three nonocclusive mesenteric ischemia patients following early diagnosis by multidetector row computed tomography and prostaglandin E1 treatment. Intern Med. 2008;47(22):2001–6. PubMed PMID: 19015617.
Kazmers A. Operative management of chronic mesenteric ischemia. Ann Vasc Surg. 1998;12(3):299–308. PubMed PMID: 9588521.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
van Oudheusden, T.R., Dekkers, M., Bode, A.S., Teijink, J.A., Luyer, M.D. (2015). Management and Results. In: Oderich, G. (eds) Mesenteric Vascular Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1847-8_26
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1847-8_26
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1846-1
Online ISBN: 978-1-4939-1847-8
eBook Packages: MedicineMedicine (R0)